Your browser doesn't support javascript.
loading
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.
Spencer, Andrew; Lentzsch, Suzanne; Weisel, Katja; Avet-Loiseau, Hervé; Mark, Tomer M; Spicka, Ivan; Masszi, Tamas; Lauri, Birgitta; Levin, Mark-David; Bosi, Alberto; Hungria, Vania; Cavo, Michele; Lee, Je-Jung; Nooka, Ajay K; Quach, Hang; Lee, Cindy; Barreto, Wolney; Corradini, Paolo; Min, Chang-Ki; Scott, Emma C; Chanan-Khan, Asher A; Horvath, Noemi; Capra, Marcelo; Beksac, Meral; Ovilla, Roberto; Jo, Jae-Cheol; Shin, Ho-Jin; Sonneveld, Pieter; Soong, David; Casneuf, Tineke; Chiu, Christopher; Amin, Himal; Qi, Ming; Thiyagarajah, Piruntha; Sasser, A Kate; Schecter, Jordan M; Mateos, Maria-Victoria.
Afiliación
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia aspencer@netspace.net.au.
  • Lentzsch S; Division of Hematology/Oncology, Columbia University, New York, NY, USA.
  • Weisel K; Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tübingen, Germany.
  • Avet-Loiseau H; Unite de Genomique du Myelome, CHU Rangueil, Toulouse, France.
  • Mark TM; Department of Medicine, University of Colorado, Aurora, CO, USA.
  • Spicka I; Clinical Department of Haematology, 1 Medical Department, Charles University in Prague, Czech Republic.
  • Masszi T; Department of Haematology and Stem Cell Transplantation, St László Hospital, 3 Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Lauri B; Department of Hematology, Sunderbyn Hospital, Luleå, Sweden.
  • Levin MD; Albert Schweitzer Hospital Department of Internal Medicine, Dordrecht, the Netherlands.
  • Bosi A; Department of Hematology, Careggi Hospital and University of Florence, Italy.
  • Hungria V; Irmandade Da Santa Casa De Misericordia De São Paulo, Brazil.
  • Cavo M; "Seràgnoli" Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
  • Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Jeollanamdo, South Korea.
  • Nooka AK; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Quach H; St. Vincent's Hospital, University of Melbourne, Australia.
  • Lee C; Royal Adelaide Hospital, North Terrace, Australia.
  • Barreto W; Hospital Santa Marcelina, São Paulo, Brazil.
  • Corradini P; Fondazione IRCCS Instituto Nazionale dei Tumori, University of Milan, Italy.
  • Min CK; Seoul St. Mary's Hospital, South Korea.
  • Scott EC; Oregon Health & Science University, Portland, OR, USA.
  • Chanan-Khan AA; Mayo Clinic Florida, Jacksonville, FL, USA.
  • Horvath N; Royal Adelaide Hospital, North Terrace, Australia.
  • Capra M; Instituto do Cancer-Hospital Mae de Deus, Porto Alegre, Brazil.
  • Beksac M; Ankara University, Turkey.
  • Ovilla R; Hospital Angeles Lomas, Naucalpan de Juárez y alrededores, México.
  • Jo JC; Ulsan University Hospital, South Korea.
  • Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, South Korea.
  • Sonneveld P; Erasmus Medical Center, Rotterdam, the Netherlands.
  • Soong D; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Casneuf T; Janssen Research & Development, Beerse, Belgium.
  • Chiu C; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Amin H; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Qi M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Thiyagarajah P; Janssen Research & Development, High Wycombe, UK.
  • Sasser AK; Genmab US, Inc, Princeton, NJ, USA.
  • Schecter JM; Janssen Research & Development, LLC, Raritan, NJ, USA.
  • Mateos MV; University Hospital of Salamanca/IBSAL, Spain.
Haematologica ; 103(12): 2079-2087, 2018 12.
Article en En | MEDLINE | ID: mdl-30237264
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Evaluación de Resultado en la Atención de Salud / Neoplasia Residual / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Evaluación de Resultado en la Atención de Salud / Neoplasia Residual / Mieloma Múltiple Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Australia